The potential benefit of endothelin receptor antagonists’ therapy in idiopathic pulmonary fibrosis: A meta-analysis of results from randomized controlled trials

Fibrotic diseases take a very heavy toll in terms of morbidity and mortality equal to or even greater than that caused by metastatic cancer. This meta-analysis aimed to evaluate the effect of endothelin receptor antagonists on idiopathic pulmonary fibrosis. METHOD: A systematic search of the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuang, Pan, Yong-li, Xin, Wenqiang, Yan, Chunhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543018/
https://www.ncbi.nlm.nih.gov/pubmed/36221345
http://dx.doi.org/10.1097/MD.0000000000029981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543018/
https://www.ncbi.nlm.nih.gov/pubmed/36221345
http://dx.doi.org/10.1097/MD.0000000000029981

Ejemplares similares